New technologies and drugs in the management of diabetic retinopathy

Abstract Diabetic retinopathy remains one of the most common and most feared causes of blindness and visual impairment in adults of working age despite the availability of effective treatment for more than 30 years. Sight‐threatening diabetic retinopathy consists of two distinct clinical entities: proliferative diabetic retinopathy (PDR) and diabetic macular oedema (DMO or maculopathy) which…